issues with semaglutide Ozempic (semaglutide) is a GLP-1 receptor agonist used for type 2 diabetes (and sometimes weight loss). Its side effects range from common GI symptoms to rare but serious risks. ⸻ 🟡 Common Should Ozempic Include a Warning

In this edition of the IPC Vendor Advantage Network Monthly Spotlight, Shannon Battle introduces Olympia Pharmaceuticals as a new preferred vendor, highlighting their expertise in sterile compounding and diverse product offerings, including NAD, weight management solutions, and specialty injectables

The infrastructure is now being built: the CMS-0057-F rule mandates FHIR-based PA APIs by January 2027, AHIP pledges are driving operational improvements since January 2026, and the Medicare GLP-1 Bridge demonstration starting July 2026 will test centralized electronic PA at unprecedented scale

A second pill, from Eli Lilly, is also expected to be approved in the coming months

Companies that leverage actionable data analytics, wearable sensors, and AI-driven coaching in real time may create enormous value in this ecosystem

This can be difficult for those unable to leave their homes